Li J, Feng S, Jia S, Zhang Y, et al. Sequential CD19/CD22 CAR-T cell therapy following ASCT shows improved efficacy versus CAR-T alone in relapsed/refractory large B-cell lymphoma. Bone Marrow Transplant 2026 Apr 14. doi: 10.1038/s41409-026-02858.
PMID: 41981078